Summit Therapeutics Inc
(NAS:SMMT)
$
13.66
-1.31 (-8.75%)
Market Cap: 10.90 Bil
Enterprise Value: 9.93 Bil
PE Ratio: 0
PB Ratio: 19.51
GF Score: 27/100 Summit Therapeutics Inc (SMMT) Transcripts
- 1